tokenized currencies- Top See results about

Ding Xiaoqiang was appointed as a member, standing committee member and secretary of Changzhi Municipal Committee. According to the news of Changzhi News VideoNo. on December 11th, Changzhi held a meeting of leading cadres in the whole city. The meeting announced the decision of the provincial party committee, and Comrade Ding Xiaoqiang was appointed as a member, standing committee member and secretary of Changzhi Municipal Committee.Market News: The Ukrainian military said that the attack on the Russian oil depot triggered a "fire".It is reported that Walgreens Boots Alliance is negotiating to sell itself to a private equity company, which will delist the drugstore chain. The company's share price has been declining for nearly ten years. According to informed sources, Wobolian and Sycamore Partners have been discussing a deal, which may be completed as early as early next year, provided that the negotiations do not break down. It is reported that the market value of Wobolian peaked at more than 100 billion US dollars in 2015, but it has shrunk to about 7.5 billion US dollars since then.

On the 11th, alumina fell by 3.61%, and the latest main contract positions changed as follows. According to the exchange data, as of December 11th, the main contract alumina 2502 closed, with a volume of 174,600 lots. The position data showed that the top 20 seats were net, and the difference position was 10,936 lots. The total turnover of alumina futures contracts was 452,500 lots, an increase of 77,000 lots over the previous day. The first 20 seats in the contract held 264,800 lots, a decrease of 4,558 lots from the previous day. The short positions in the top 20 seats of the contract were 215,500 lots, a decrease of 1,290 lots from the previous day. (Sina Futures)Kaidianbao suspended the payment business. On December 11th, Kaidianbao Payment Service Co., Ltd. announced that due to the change of business conditions, in order to protect the interests of merchants and partners to the greatest extent, the company decided to suspend the payment business, and from now on, the existing stock business will be withdrawn and cleaned in an orderly manner, and the businesses with potential risks will be cleaned up before December 20th, 2024. All stock payment services will be suspended after December 31, 2024. Regarding why the business was suspended, the reporter interviewed the legal representative of the company, but did not get a response from the other party. (beijing business today)Kanglongda: The company's products have not been directly sold to humanoid robots and aerospace manufacturing-related enterprises. Kanglongda said on the interactive platform on December 11 that the ultra-high molecular weight polyethylene (UHMWPE) fibers produced by the company are mainly used for industrial synergy, and the products sold abroad are mainly used in the fields of national defense and police, rope nets and belts. Up to now, the company's products have not been directly sold to humanoid robots and aerospace manufacturing related enterprises.

On the 11th, CSI 1000 index futures rose by 1.01%, and the latest main contract positions changed as follows. According to the exchange data, as of December 11th, the main contract CSI 1000 index futures closed at 2,412, up or down by +1.01%, with a turnover of 147,000 lots. The position data showed that the top 20 seats were clear, and the difference position was 7,210 lots. The total number of contracts of CSI 1000 index futures was 235,100 lots, a decrease of 70,300 lots from the previous day. The first 20 seats in the contract held 237,700 lots, a decrease of 17,700 lots from the previous day. The short positions in the top 20 seats of the contract were 266,100 lots, a decrease of 16,500 lots from the previous day. (Sina Futures)Xpeng Motors: Tucki P7+ completed the formal delivery of 10,000 Tucki P7+ sets within four weeks after listing.Modern Pharmaceuticals: Sinopharm Zhijun, the holding subsidiary, obtained the drug registration certificate of Cefotaxime Tablets. Modern Pharmaceuticals announced that Sinopharm Zhijun Pharmaceutical Co., Ltd., the holding subsidiary, recently received the Drug Registration Certificate of Cefotaxime Tablets approved and issued by National Medical Products Administration. Cefopoxime axetil tablets are the third generation cephalosporins taken orally, which are used to treat upper respiratory tract infections and lower respiratory tract infections caused by sensitive bacteria. In 2023, the global sales of preparations will be USD 370 million, and the sales of public hospitals nationwide will be RMB 102 million. The accumulative R&D investment of Sinopharm Zhijun is about RMB 28.45 million. Obtaining the registration certificate will enrich the company's product line, increase market competitiveness and have a positive impact on the company's future development. However, drug sales are easily affected by factors such as policies and market environment, and there are uncertainties.